Pine Bridge Investments, L.P. Amgen Inc Transaction History

Pine Bridge Investments, L.P.

$12.4 Billion
Q1 2024

A detailed history of Pine Bridge Investments, L.P. transactions in Amgen Inc stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 85,505 shares of AMGN stock, worth $26.6 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

85,505

Previous 120,401 28.98%

Holding current value

$26.6 Million

Previous $34.7 Million 29.9%

% of portfolio

0.2%

Previous 0.32%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $9.38 Million - $11.3 Million	-34,896 Reduced 28.98%	85,505 $24.3 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $12.3 Million - $13.9 Million	48,099 Added 66.53%	120,401 $34.7 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $3.36 Million - $4.17 Million	15,369 Added 26.99%	72,302 $19.4 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $25.4 Million - $30 Million	-118,585 Reduced 67.56%	56,933 $12.6 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $11.3 Million - $13.8 Million	50,259 Added 40.12%	175,518 $42.4 Million

Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $23 Million - $29.3 Million	-100,524 Reduced 44.52%	125,259 $32.9 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $14.3 Million - $16.1 Million	63,576 Added 39.19%	225,783 $50.9 Million
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $12.8 Million - $14.2 Million	-55,268 Reduced 25.41%	162,207 $39.5 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $7.87 Million - $8.71 Million	-35,900 Reduced 14.17%	217,475 $52.6 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $2.2 Million - $2.52 Million	11,070 Added 4.57%	253,375 $57 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $46.3 Million - $54.3 Million	218,323 Added 910.36%	242,305 $51.5 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $4.57 Million - $5.07 Million	-19,571 Reduced 44.94%	23,982 $5.85 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $17.5 Million - $20.4 Million	-79,028 Reduced 64.47%	43,553 $10.8 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $5.66 Million - $6.74 Million	26,162 Added 27.13%	122,581 $28.2 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $3.21 Million - $3.57 Million	-13,689 Reduced 12.43%	96,419 $24.5 Million
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $2.7 Million - $3.31 Million	13,644 Added 14.14%	110,108 $26 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $5.2 Million - $6.89 Million	28,523 Added 41.98%	96,464 $19.6 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $300,654 - $386,444	-1,589 Reduced 2.29%	67,941 $16.4 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $39 Million - $46.8 Million	-224,250 Reduced 76.33%	69,530 $13.5 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $7.3 Million - $8.55 Million	43,770 Added 17.51%	293,780 $54.1 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $6.83 Million - $7.69 Million	37,739 Added 17.78%	250,010 $47.5 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $4.98 Million - $5.82 Million	-27,934 Reduced 11.63%	212,271 $41.3 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $16.8 Million - $18.9 Million	90,588 Added 60.55%	240,205 $49.8 Million
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $97,305 - $109,294	-586 Reduced 0.39%	149,617 $27.6 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $602,323 - $703,890	3,555 Added 2.42%	150,203 $25.6 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $1.84 Million - $2.05 Million	-10,893 Reduced 6.91%	146,648 $25.5 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $1.42 Million - $1.62 Million	-8,492 Reduced 5.11%	157,541 $29.4 Million
Q2 2017 Aug 11, 2017	BUY	N/A	166,033	166,033 $28.6 Million

Others Institutions Holding AMGN

# of Institutions

2,932

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.

Account

Pine Bridge Investments, L.P. Amgen Inc Transaction History